Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Durbesson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Gut Microbes|March 20, 2026
Discovery of a secreted <i>Bacteroides fragilis</i> mucinase that cleaves mucins with bis-T O-glycans through a carbohydrate binding module-dependent mechanismYoshiki Narimatsu, Cayetano Pleguezuelos-Manzano, Daniel Hornikx, et al.
Toxins|December 22, 2023
ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite EnvenomingStefanie K Menzies, Raquel Arinto-Garcia, Fernanda Gobbi Amorim, et al.
Nature Communications|July 2, 2021
Display of the human mucinome with defined O-glycans by gene engineered cellsRebecca Nason, Christian Büll, Andriana Konstantinidi, et al.
Antibody Therapeutics|December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Gut Microbes|March 20, 2026
Discovery of a secreted <i>Bacteroides fragilis</i> mucinase that cleaves mucins with bis-T O-glycans through a carbohydrate binding module-dependent mechanismYoshiki Narimatsu, Cayetano Pleguezuelos-Manzano, Daniel Hornikx, et al.
Toxins|December 22, 2023
ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite EnvenomingStefanie K Menzies, Raquel Arinto-Garcia, Fernanda Gobbi Amorim, et al.
Nature Communications|July 2, 2021
Display of the human mucinome with defined O-glycans by gene engineered cellsRebecca Nason, Christian Büll, Andriana Konstantinidi, et al.
Antibody Therapeutics|December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Pageof 2